Innovative Single-Cell Platform Singleron Biotechnologies specializes in cutting-edge high-throughput single-cell analysis technologies, making their product portfolio attractive to labs and institutions seeking advanced multi-omics solutions for faster and more accurate research and diagnostics.

Global Expansion & Partnerships With offices and labs across Germany, US, Singapore, and China, along with recent distributor partnerships in Asia and collaborations with the Human Cell Atlas, the company demonstrates strong international growth potential and opportunities for expanding sales channels worldwide.

Recent Product Launches The introduction of innovative products like Tensor, MobiuSCOPE, and the sCelLiVE Tissue Dissociation Kit indicates an active pipeline of solutions that can address various research needs, providing multiple upsell and cross-sell opportunities within existing customer bases.

Research & Diagnostics Focus Targeting clinical research, diagnostics, and drug development markets, Singleron’s offerings are well-positioned to appeal to biotech and pharma companies investing in advanced single-cell technologies, creating boundaries for direct enterprise sales opportunities.

Growing Revenue & Market Presence With an estimated revenue of up to $25 million and a dedicated team of 51 to 200 employees, the company has demonstrated significant growth focus. This scale suggests increasing demand for their solutions, presenting opportunities to introduce new products and expand into new research sectors.